Licensing agreement will support Oxford Genetics growing bio-therapeutic discovery, development and manufacturing service business. Oxford – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery and development, today announces it has signed a non-exclusive licensing agreement with ERS Genomics to access its foundational intellectual property related to CRISPR/Cas9 gene editing technology. […]
Boulder, CO – Muse bio, a privately-held company leading the development of next-generation genome engineering capabilities, today announced Dr. John Stuelpnagel, co-founder, first CEO and former COO of Illumina and a well-known genomics industry entrepreneur, will become Chairman of Muse bio’s Board of Directors. In addition to Illumina, Dr. Stuelpnagel has co-founded and held senior […]
Acquisition strengthens portfolio with best-selling labelling technology Lightning Link® Combined 2017 pro-forma revenues expected to exceed EUR 10 million Acquisition to be financed by way of a rights issue and a private placement excluding pre-emptive rights with total proceeds of up to EUR 10 mio Two million shares to be offered to Innova shareholders as […]
We’re thrilled on announce that we’ll be unveiling the newest addition to our bioinformatics portfolio – CLC Genomics Cloud Engine – at this year’s Bio IT World Conference & Expo! Join us in Boston, May 23-25, and register for early access for our new enterprise-wide solution which allows you to analyse NGS data where they […]
AMSBIO has introduced a new range of ready-to-use Reporter Lentivirus for assessing cell signaling activities in virtually any mammalian cell type. These pre-made products use a unique combination of transcription factor reporter technology coupled with lentiviral delivery to provide a simple, highly sensitive method capable of operating over a large dynamic range. By measuring the […]
MORGANTOWN, W.Va. and KALAMAZOO, Mich. — Protea Biosciences Group, Inc. (OTCQB: PRGB) (“Protea”) and Proteos, Inc. (“Proteos”) announced today that they have entered into a joint co-marketing agreement. This mutual partnership allows Protea to combine Proteos’ protein production capabilities alongside Protea’s proprietary bioanalytical services, and allows Proteos to market and promote Protea’s proprietary bioanalytical services with their […]
Research insights from ultra-rapid whole genome sequencing are being used at California’s largest children’s hospital to improve care of critically-ill newborns MOUNTAIN VIEW, Calif.—-DNAnexus, the global leader in genome informatics and data management, announced that Rady Children’s Institute for Genomic Medicine (RCIGM) in San Diego has adopted the DNAnexus Platform to enable the world’s fastest […]
Researchers in Switzerland no longer need to import IDT products; local expertise facilitates ordering SKOKIE, IL – Integrated DNA Technologies (IDT), has signed a distributor agreement with LubioScience GmbH (LubioScience), based in Lucerne, Switzerland. Through LubioScience, researchers in Switzerland will benefit from local access to IDT’s full range of high quality reagents for genomics research, including […]
Partnership with a leading Chinese IVD company with goal to accelerate penetration of the world’s first complete Sample to Insight NGS solution in rapidly growing Chinese market Hilden, Germany, and Chengdu, China – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the formation of a joint venture with Maccura Biotechnology Co., Ltd., a […]
SAN FRANCISCO — Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced the appointment of Mark Daniels to the newly-created position of chief ethics and compliance officer. Mr. Daniels will maintain his current position as Twist Bioscience’s general counsel, and in his expanded role, will oversee the company’s ethics and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
